DILIP BUILDCON LTD Q4 RESULTS

​​Interarch is what we recently added, of course, at significantly lower levels and it has run up quite well, it is into prefab structure, it is a bottom-up stock picking that we did and there the opportunity is very-very large, unorganised to organ...

From another China stimulus, to the US Fed’s actions, to the US elections. The coming days will be dominated by global news flows. Add to this mix the Q2 results season – with numbers mostly below the street's expectations. So the market might see m...

Afcons Infrastructure's IPO, a Shapoorji Pallonji company, was fully subscribed on the last day with the issue receiving bids 1.10 times the total size. The retail portion saw 52% subscription while non-institutional investors subscribed 2.42 times....

Afcons Infrastructure's IPO was only 18% subscribed on day two. Analysts recommend long-term investment, citing a strong business model despite challenges like low profit margins and government dependency.

Sun Pharmaceutical Q2 FY25 Results: Sun Pharma reported a 28% increase in consolidated net profit for Q2, reaching Rs 3,040 crore, up from Rs 2,375 crore last year. Revenue rose 9% YoY to Rs 13,291 crore, surpassing market estimates. EBITDA grew 24%...

More than the Nifty and Sensex taking a beating, what has been bothering the street and worrying investors is the lack of market breadth these past few days. The risk of the situation getting worse if the indices remain under pressure is high. Also,...

The June quarter saw Zomato and 10 other companies achieving over 1,000% profit growth. Zomato's profit skyrocketed 12,550% year-on-year. Other remarkable performers were Shakti Pumps and Lotus Chocolate. Experts advise focusing on growth outlooks r...

Coalition politics often requires a delicate balancing act, with the government catering to diverse interests. This could lead to a more populist Budget aimed at appealing to a wider range of voters. However, considering the Modi government's histor...

Nifty gained 1.2%, driven by IT, energy, and pharma stocks. U.S. labor data, TCS earnings, Rupee vs. Dollar, Bank Nifty, oil prices, FIIs, IPO action, and dividends will influence markets next week. Bulls maintain strength with positive sentiment an...

Sun Pharma Q4 Results: The company's revenue rose 10% year-on-year to Rs 11,983 crore in the reporting quarter. It was Rs 10,931 crore a year ago. Its board has approved a final dividend of Rs 5 per share, which will be paid within the prescribed ti...

162 companies to report Q4 earnings on Wednesday. Nykaa expects 24% BPC and Fashion GMV growth, while Paytm faces a revenue decline from RBI actions. Analysts also predict pressure from discounting and lower advertising income.

ITC, ONGC, IRFC, Ircon International, BHEL, BEL, Sun Pharma, Nykaa, Tata Investment Corporation, Hindalco, Ashok Leyland, and Divi's lab will be releasing their March quarter report cards this week.

The CBI has booked a PNB official for allegedly siphoning off Rs 4.98 crore from the account of a Bhopal-based infrastructure construction company in collusion with a private person. The incident occurred at PNB's Delhi Road Branch in Hapur, Uttar P...

Various widely tracked companies like Tata Motors, SBI, Asian Paints, BPCL, Larsen & Toubro, Tata Power, Canara Bank, TVS Motor, Hero MotoCorp, Godrej Consumer Products, JSW Energy, Dr. Reddy's Laboratories, PB Fintech, and Bank of Baroda will be re...

Sun Pharmaceutical Industries reported a 17.4% YoY growth in net profit for Q4, beating estimates. Consolidated revenue grew 10% YoY. The company recommended an interim dividend payout. EBITDA rose 16% YoY and margins expanded. Raw material cost fel...

Soon after the announcement by the US Fed two weeks back, the mood on the Street has once again turned in favor of bulls. Whether it is Sensex or Nifty, the underlying bias has once again turned bullish, specially in midcap space. But one headwind r...

The company approved a final dividend of Rs 4 per equity share which will be subject to the approval of the shareholders. The total dividend payout for FY23 is Rs 11.5 per share compared to Rs 10 per share for FY22.

Sun Pharma posted a net profit of INR 1,985 crore ($266m) in Q4 FY23 due to increased specialty drug sales and strong growth in domestic formulations and emerging markets. The firm made a net loss of INR 2,277 crore in the same quarter of the previo...

Karnataka was the first state election in the series of elections which we will witness in 2023 before the general election of 2024. The government spending on infrastructure projects, which has remained at elevated levels for many years, may see a ...